A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2004
12/22/2004	EP1487458A2 Multi-substitued selective androgen receptor modulators and methods of use thereof
12/22/2004	EP1487457A1 Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation
12/22/2004	EP1487456A1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
12/22/2004	EP1487455A1 Morpholine derivatives substituted at the 2-position by an arylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions
12/22/2004	EP1487454A1 Morpholine derivatives substituted at the 2-position by a heterocyclylalkylurea group for use as ccr-3 antagonists in the treatment of inflammatory conditions
12/22/2004	EP1487453A1 N- [(2s)-4-(3,4-difluorobenzyl)morpholin-2-yl]methyl -2- 3-[(methylsulphonyl)amino]phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions
12/22/2004	EP1487452A1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl -benzamide for treating seminomas
12/22/2004	EP1487451A1 Inhibition of cell death responses induced by oxidative stress
12/22/2004	EP1487449A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
12/22/2004	EP1487448A1 Treatment of effect of chemicals with their ultradilute stereoisomers
12/22/2004	EP1487447A1 Use of proton pump inhibitors for the treatment of airway disorders
12/22/2004	EP1487446A2 Bicyclic heterocycles for the treatment of diabetes and other diseases
12/22/2004	EP1487445A1 Obidoxime dimesylate
12/22/2004	EP1487444A1 Use of pyridyl amides as inhibitors of angiogenesis
12/22/2004	EP1487443A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
12/22/2004	EP1487442A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
12/22/2004	EP1487441A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
12/22/2004	EP1487440A1 A use of treatment for fungal infections with a synergistic formulation of antifungal agents
12/22/2004	EP1487439A1 Solubilization of weak bases
12/22/2004	EP1487438A2 Compositions and methods for treating glaucoma and ocular hypertension
12/22/2004	EP1487437A1 Methods of treatment with selective ep4 receptor agonists
12/22/2004	EP1487436A1 Combination therapy for treating, preventing or managing proliferative disorders and cancers
12/22/2004	EP1487435A1 Azetidine derivatives as ccr-3 receptor antagonists
12/22/2004	EP1487434A2 Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
12/22/2004	EP1487433A1 Anti-cancer combinations of dmxaa and a nsaid
12/22/2004	EP1487432A2 Suramin and derivatives thereof as topical microbicide and contraceptive
12/22/2004	EP1487431A1 Preventing and/or treating cardiovascular disease and/or associated heart failure
12/22/2004	EP1487430A1 Methods for treating diseases related to intraocular pressure
12/22/2004	EP1487429A2 Compositions of venlafaxine base
12/22/2004	EP1487428A2 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
12/22/2004	EP1487427A1 Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline
12/22/2004	EP1487426A2 Methods of inducing terminal differentiation
12/22/2004	EP1487425A2 Use of a vanilloid as an anti-snoring element
12/22/2004	EP1487424A2 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
12/22/2004	EP1487423A1 Novel formulation
12/22/2004	EP1487421A2 Pharmaceutical formulation for the active ingredient budesonide
12/22/2004	EP1487420A1 Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
12/22/2004	EP1487418A1 Co-beadlet of dha and rosemary and methods of use
12/22/2004	EP1487417A2 Dry powder medicament formulations
12/22/2004	EP1487416A2 Drug microparticles
12/22/2004	EP1487414A2 Antibiotic composition
12/22/2004	EP1487413A1 An inhalation system for prevention and treatment of intracellular infections
12/22/2004	EP1487412A1 Chemosensitizing with liposomes containing oligonucleotides
12/22/2004	EP1487411A2 Inhalable sustained therapeutic formulations
12/22/2004	EP1487410A2 Preparation of sterile stabilized nanodispersions
12/22/2004	EP1487408A1 Topical composition based on ion-exchange resins, in particular for treating erythemas
12/22/2004	EP1487406A1 Heat-reversible composition treating hyposalia and asialia
12/22/2004	EP1487404A1 Use of compatible solutes for inhibiting the release of ceramides
12/22/2004	EP1487400A2 Cosmetic agents
12/22/2004	EP1487285A1 Alertness bar
12/22/2004	EP1487272A1 Choline-silicic acid complex with osmolytes and divalent trace elements
12/22/2004	EP1487269A1 Autoinducer compounds
12/22/2004	EP1436266A4 Methods and compositions of novel triazine compounds
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1373264B1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors
12/22/2004	EP1355635B1 New film coating
12/22/2004	EP1353678A4 Method for alleviating syndromes and conditions of discomfort of the mammalian intestinal and genito-urinary tracts
12/22/2004	EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1280766B1 Biocidal polymers based on guanidine salts
12/22/2004	EP1274408B1 Use of natural chrysanthone compounds having antiangiogenic activity
12/22/2004	EP1189907B1 Thienopyrimidines as phosphodiesterase inhibitors
12/22/2004	EP1172108B1 Use of Sulfoquinovosyldiacylglycerol derivatives as immunosuppressants
12/22/2004	EP1140090B1 Use of phanquinone for the treatment or prevention of memory impairment
12/22/2004	EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004	EP1121363B1 6-SUBSTITUTED PYRAZOLO(3,4-d)PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
12/22/2004	EP1115373B1 Oral composition with an improved teeth whitening effect
12/22/2004	EP1080066A4 Bioreductive cytotoxic agents
12/22/2004	EP1052985B1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid and sodium salts thereof for iron chelating therapy
12/22/2004	EP1051172B1 Method for treating copd
12/22/2004	EP1009368B1 Hair conditioners for treating split ends
12/22/2004	EP1007043B9 Method for treatment of cns-involved lysosomal storage diseases
12/22/2004	EP1003476B1 Prolonged release active agent dosage form adapted for gastric retention
12/22/2004	EP0987254B1 Novel cyclic diamine compounds and medicine containing the same
12/22/2004	EP0956026B1 Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics
12/22/2004	EP0927030B1 Use of aryl n-substituted carboxamides to kill tumors
12/22/2004	EP0906110B1 Dna vaccine formulations
12/22/2004	EP0896534B1 Injection formulations of avermectins and milbemycins based on castor oil
12/22/2004	EP0825877B1 Composition for prevention of posterior capsule opacification
12/22/2004	EP0809437B1 Thiols to promote hematopoietic progenitor cell growth
12/22/2004	EP0799045B2 Treatment of hyperexcited nerve cell functions
12/22/2004	EP0768889B1 Cancer therapy using lymphotoxin
12/22/2004	EP0746294B1 Absorption enhancers for topical pharmaceutical formulations
12/22/2004	EP0732928B1 Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
12/22/2004	CN1556828A Hydrophili polymer derirative having Y shaped branch, its preparation method, combined object with medicine molecule and medical compositon containing combined object
12/22/2004	CN1556811A 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/22/2004	CN1556810A Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
12/22/2004	CN1556809A Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives
12/22/2004	CN1556808A Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosme
12/22/2004	CN1556807A Chemical compounds
12/22/2004	CN1556805A Piperidine derivative as NMDA receptor antagonist
12/22/2004	CN1556804A 3-substituted-4-pyrimidone derivatives
12/22/2004	CN1556801A Hydrophilipolymer and flavone combined object and medicinal composition containing said combined object
12/22/2004	CN1556800A Process for the preparation of citalopram
12/22/2004	CN1556797A Substituted isoxazole compound and its application as antibiotics
12/22/2004	CN1556795A 3-desoxy-vitamin D3 analog esters
12/22/2004	CN1556788A Muscarinic agonists
12/22/2004	CN1556720A Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
12/22/2004	CN1556716A Modular infusion device and method
12/22/2004	CN1556712A Pharmaceutical compositions containing DDS compounds
12/22/2004	CN1556709A Methods for treating stress disorders using glucocorticoid receptor-specific antagonists

1 ... 4852 4853 4854 4855 4856 4857 4858 4859 4860 4861 4862 4863 4864 4865 4866 4867 4868 4869 4870 4871 4872 ... 7860